Beijing Challen Biotechnology Co., Ltd. articles

In the recent years, with continuous development of life science research and continuous growth of clinical diagnostic needs, flow cytometer market experienced remarkable growth. More and more scientific research organizations and medical institutions have realized the importance of flow cytometry and increased their investment, which has led to the expansion of flow cytometry market. In order to understand flow cytometer market in China, the Instrument Information Network (仪器信息网) h

In regard to the new controls addressing US security risks in Biotechnology, on January, 20th, Chinese Instrument Information Network arranged a live broadcast called "Facing the US Flow Cytometer Export Ban" to analyze the development of Chinese flow cytometers and discuss the challenges and opportunities that Chinese flow cytometers may face in response to the sudden export ban by the United States.
Mr. Liu Teaford, CEO of Challenbio, a leading Chinese flow cytometer manufacturer, and

FongCyte™ flow cytometer by Challenbio promotes the innovative application of biomaterial gallium sulfide in tumor synergistic therapy.

In August 2025, the Key Laboratory of the Institute of Functional Nano & Soft Materials in Soochow University published an article titled "A Two-Pronged Nanostrategy of Iron Metabolism Disruption to Synergize Tumor Therapy by Triggering the Paraptosis−Apop

Dr. Sun Daqian , a well-known expert in the field of flow cytometry and currently the technical director of the stem cell flow cytometry and xenotransplantation platform at Albert Einstein College of Medicine in New York, and Dr. Paul Hutchinson, the head of flow cytometry center of the immunology program at the National University of Singapore, use FongCyte™ flow cytometer by #Challenbio to e

On October 26th, at the 16th National Immunology Academic Conference, Beijing Challen Biotechnology Co., Ltd. ran a new product launch event with the theme of "Full Spectrum, New Horizons, Deep Insights", and proudly unveiled its first full-spectrum flow cytometer hashtag CytoStellar. CytoStellar is not only like a bright star illuminating life- science research and merging into the galaxy, it is more like a brave explorer, promoting the development of Chinese flow cytometry industry.

In 2022 Challenbio successively released three-laser flow cytometers LongCyte™ (clinical type) and FongCyte™ (research type) and by April 2024, the two instruments have promoted the publication of 8 articles in the international journals, 4 of the articles have IF (Impact factor) ≥ 10, with the highest IF being 15.82.

✅ Product：FongCyte™
Article: Hepatic-Accumulated Obeticholic Acid and Atorvastatin Self-Assembled Nanocrystals Potentiate Ameliorative Effects in Treat

If you ask anyone who attended CYTO2024, what impressed them the most about CYTO 2024, most visitors are likely to mention the rise of imaging technology.

We will analyze imaging flow cytometry from three aspects: hardware, software, and standardization.

Hardware: Spectral imaging, microfluidics

The molecular information represented by spectrum and the morphological information represented by images will form the basis for the future cytometry. However, c

A leading chinese manufacturer of flow cytometers and reagent kits Challenbio (Beijing Challen Biotechnology Co., Ltd.) will take part in ISAC’s 37th International
Congress for the Advancement of Cytometry, which will be held from May 4-8, 2024, in Edinburgh, Scotland. 

The company will bring its best-selling 3-laser 14-color flow cytometer LongCyte to

Fongcyte Flow Cytometer by Challenbio was featured in the news report of Hunan Television!

Research-type flow cytometer Fongcyte was installed in Wuhan Institute of Industrial Innovation and Development with the assistance of Wuhan Nabo Life Technology Co., Ltd.

Th